Speaker illustration

Professor Harry Crijns

Maastricht University Medical Centre (MUMC), Maastricht (Netherlands (The))

Member of:

European Heart Rythm Association

Graduated in medicine at the University of Amsterdam in 1981, he completed his cardiology training at the University Medical Centre Groningen, The Netherlands in 1987, where he continued working as clinical cardiologist and electrophysiologist. He obtained a PhD at the University of Groningen in 1993 on 'Changes of Intracardiac Conduction Induced by Anti-arrhythmic Drugs - Importance of Use and Reverse Use-dependence'. He currently is emeritus professor of Cardiology, Maastricht University and Cardiovascular research Institute Maastricht (CARIM). Contributions to the field include improved rate/rhythm control (RACE-trials, HATCH score), stroke prevention (CHA2DS2-VASc) and bleeding in AF (HAS-BLED). Current interests: idiopathic AF, atherothrombotic mechanisms in AF progression; hybrid AF ablation; early rhythm control in high risk AF.

Moderated ePosters - Basics of arrhythmias

Event: EHRA 2022

Topic: Cardiac Diseases

Session type: Moderated Posters

Thumbnail

Hein Wellens Memorial ECG session

Event: EHRA 2022

Topic: Electrocardiography (ECG)

Session type: Special Session

Thumbnail

ECG competition

Event: EHRA 2022

Topic: Electrocardiography (ECG)

Session type: Special Session

Thumbnail

Atrial arrhythmias and anticoagulation: challenging clinical scenarios

Event: ESC Congress 2021 - The Digital Experience

Topic: Atrial Fibrillation (AF)

Session type: Symposium

Thumbnail

EHRA practical guide to NOAC use in atrial fibrillation

Event: EHRA 2021

Topic: Oral Anticoagulation

Session type: Special Session

Thumbnail

Young Investigator Award - Basic and Translational Science

Event: EHRA 2021

Topic: European Heart Rhythm Association (EHRA)

Session type: Award Sessions

Thumbnail

Innovative technology

Event: EHRA 2021

Topic: Arrhythmias, General

Session type: Special Session

Thumbnail

Blockbusters from the Young in atrial fibrillation and cardiac resynchronisation therapy

Event: ESC CONGRESS 2019

Topic: Treatment

Session type: Abstract Sessions

Thumbnail

Knowledge gaps in clinical atrial fibrillation

Event: EHRA 2019

Topic: Treatment

Session type: Debate Session

Thumbnail

Burning issues in atrial fibrillation: device AF burden and the role of lifestyle changes

Event: EHRA 2018

Topic: Novel Therapies for Stroke in Atrial Fibrillation

Session type: Debate Session

Thumbnail

This platform is supported by

logo Novo Nordisk